You're reading the free version. Trader adds the live tape and alerts.
Start tracking
AIM Buy Disclosure
Equels Thomas K · SEC Form 4 · Filed Nov 6, 2026
Buy
Calculated transaction value
$3.17K
Equels Thomas K CEO & President
AIM
Transaction date
Nov 6, 2026
Public filing date
Nov 6, 2026
Filing lag
Filed same day
AIM daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 20,299 shares @ $0.16
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001493152-26-050412
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$3.17K
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Aim Immunotech Inc. AIM Current | Buy | Nov 6, 2026 | $3.17K |